CareLit · DOI-Nachweis · Pneumologie
Intercalated TKI and chemotherapy induction in EGFR mt+ NSCLC stage IIIA and IIIB: report of 3 cases with complete pathologic remission in mediastinal lymph nodes
DOI 10.1055/s-0036-1572236
Bibliografische Angaben
Nachweis in CareLit
Autor:innenF Griesinger, A Lüers, M Falk, I Conradi, M Reinhardt, A Kluge, K Willborn, R Prenzel, DC Scriba, R Henke, W Eberhardt, C Hallas, M Tiemann
ZeitschriftPneumologie
Ausgabe02/2016
Jahrgang / SeitenNicht angegeben
Kernaussage aus der Literatur
Abstract-Vorschau
Background: EGFR TKI treatment is standard of care in patients with metastasized NSCLC carrying an activating EGFR mutation. However, induction concepts in locally advanced NSCLC with EGFR mutation have not been studied extensively. Recently new focus has been shed on intercalated regimens of chemotherapy and TKI, showing improved PFS as well as OS. This concept was used as induction regimen in 3 patients with activ…
Zitieren
Zitierempfehlung
F Griesinger, A Lüers, M Falk, I Conradi, M Reinhardt, A Kluge, K Willborn, R Prenzel, DC Scriba, R Henke, W Eberhardt, C Hallas, M Tiemann (2016) Intercalated TKI and chemotherapy induction in EGFR mt+ NSCLC stage IIIA and IIIB: report of 3 cases with complete pathologic remission in mediastinal lymph nodes. Pneumologie (02). https://doi.org/10.1055/s-0036-1572236
Mit CareLit weiterarbeiten